Related references
Note: Only part of the references are listed.The LncRNA RP11-279C4.1 Enhances the Malignant Behaviour of Glioma Cells and Glioma Stem-Like Cells by Regulating the miR-1273g-3p/CBX3 Axis
Faming Wang et al.
MOLECULAR NEUROBIOLOGY (2021)
TIPE3 promotes non-small cell lung cancer progression via the protein kinase B/extracellular signal-regulated kinase 1/2-glycogen synthase kinase 3β-β-catenin/Snail axis
Qiang Li et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2021)
Anticancer Mechanism of Curcumin on Human Glioblastoma
Shu Chyi Wong et al.
NUTRIENTS (2021)
Circ-EZH2 knockdown reverses DDAH1 and CBX3-mediated cell growth and invasion in glioma through miR-1265 sponge activity
Fengquan Gao et al.
GENE (2020)
LncRNA LINC00998 inhibits the malignant glioma phenotype via the CBX3-mediated c-Met/Akt/mTOR axis
Haiping Cai et al.
CELL DEATH & DISEASE (2020)
NUSAP1 potentiates chemoresistance in glioblastoma through its SAP domain to stabilize ATR
Yuzu Zhao et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Integrated analysis of 34 microarray datasets reveals CBX3 as a diagnostic and prognostic biomarker in glioblastoma
Siqi Wang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
CBX3/HP1γ promotes tumor proliferation and predicts poor survival in hepatocellular carcinoma
Xiaoping Zhong et al.
AGING-US (2019)
CBX3 promotes glioma U87 cell proliferation and predicts an unfavorable prognosis
Shu-Peng Zhao et al.
JOURNAL OF NEURO-ONCOLOGY (2019)
EGFR heterogeneity and implications for therapeutic intervention in glioblastoma
Eskil Eskilsson et al.
NEURO-ONCOLOGY (2018)
CBX3 promotes proliferation and regulates glycolysis via suppressing FBP1 in pancreatic cancer
Lian-Yu Chen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
The E3 ubiquitin ligase NEDD4 mediates cell migration signaling of EGFR in lung cancer cells
Genbao Shao et al.
MOLECULAR CANCER (2018)
Current state of immunotherapy for glioblastoma
Michael Lim et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Identifying the substrate proteins of U-box E3s E4B and CHIP by orthogonal ubiquitin transfer
Karan Bhuripanyo et al.
SCIENCE ADVANCES (2018)
Drug and disease signature integration identifies synergistic combinations in glioblastoma
Vasileios Stathias et al.
NATURE COMMUNICATIONS (2018)
CBX3/heterochromatin protein 1 gamma is significantly upregulated in patients with non-small cell lung cancer
Shih-Chieh Chang et al.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2018)
CSN6 controls the proliferation and metastasis of glioblastoma by CHIP-mediated degradation of EGFR
J. Hou et al.
ONCOGENE (2017)
Overcoming therapeutic resistance in glioblastoma: the way forward
Satoru Osuka et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas
Michael Weller et al.
LANCET ONCOLOGY (2017)
Homeobox C9 suppresses Beclin1-mediated autophagy in glioblastoma by directly inhibiting the transcription of death-associated protein kinase 1
Fan Xuan et al.
NEURO-ONCOLOGY (2016)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
Glioblastoma: pathology, molecular mechanisms and markers
Kenneth Aldape et al.
ACTA NEUROPATHOLOGICA (2015)
Heterochromatin Protein HP1γ Promotes Colorectal Cancer Progression and Is Regulated by miR-30a
Ming Liu et al.
CANCER RESEARCH (2015)
Genomic and Functional Analysis of the E3 Ligase PARK2 in Glioma
De-Chen Lin et al.
CANCER RESEARCH (2015)
Expression profile of parkin isoforms in human gliomas
Grazia Maugeri et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
Homeodomain-interacting protein kinase 2 regulates DNA damage response through interacting with heterochromatin protein 1γ
Y. Akaike et al.
ONCOGENE (2015)
OPINION Heterogeneity of epidermal growth factor receptor signalling networks in glioblastoma
Frank B. Furnari et al.
NATURE REVIEWS CANCER (2015)
Challenges to targeting epidermal growth factor receptor in glioblastoma: escape mechanisms and combinatorial treatment strategies
Patrick Roth et al.
NEURO-ONCOLOGY (2014)
Targeted molecular therapies against epidermal growth factor receptor: Past experiences and challenges
David A. Reardon et al.
NEURO-ONCOLOGY (2014)
Glioma tumor grade correlates with parkin depletion in mutant p53-linked tumors and results from loss of function of p53 transcriptional activity
J. Viotti et al.
ONCOGENE (2014)
CHIP is a novel tumor suppressor in pancreatic cancer and inhibits tumor growth through targeting EGFR
Tianxiao Wang et al.
ONCOTARGET (2014)
Tid1-L Inhibits EGFR Signaling in Lung Adenocarcinoma by Enhancing EGFR Ubiquitinylation and Degradation
Chi-Yuan Chen et al.
CANCER RESEARCH (2013)
The Somatic Genomic Landscape of Glioblastoma
Cameron W. Brennan et al.
CELL (2013)
RTOG 0211: A Phase 1/2 Study of Radiation Therapy With Concurrent Gefitinib for Newly Diagnosed Glioblastoma Patients
Arnab Chakravarti et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
S-Nitrosylation of parkin as a novel regulator of p53-mediated neuronal cell death in sporadic Parkinson's disease
Carmen R. Sunico et al.
MOLECULAR NEURODEGENERATION (2013)
Proteomic and genomic approaches reveal critical functions of H3K9 methylation and heterochromatin protein-1γ in reprogramming to pluripotency
Rupa Sridharan et al.
NATURE CELL BIOLOGY (2013)
Current understanding of the role and targeting of tumor suppressor p53 in glioblastoma multiforme
Bryant England et al.
TUMOR BIOLOGY (2013)
Parkin Pathway Activation Mitigates Glioma Cell Proliferation and Predicts Patient Survival
Calvin W. S. Yeo et al.
CANCER RESEARCH (2012)
Pathway Analysis of Glioblastoma Tissue after Preoperative Treatment with the EGFR Tyrosine Kinase Inhibitor Gefitinib-A Phase II Trial
Monika E. Hegi et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Parkin, a p53 target gene, mediates the role of p53 in glucose metabolism and the Warburg effect
Cen Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
Role of the Epigenetic Regulator HP1γ in the Control of Embryonic Stem Cell Properties
Maia Caillier et al.
PLOS ONE (2010)
Blinded by the Light: The Growing Complexity of p53
Karen H. Vousden et al.
CELL (2009)
Structural biology of the p53 tumour suppressor
Andrei L. Okorokov et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2009)
Therapeutic Inhibition of the Epidermal Growth Factor Receptor in High-Grade Gliomas: Where Do We Stand?
Georg Karpel-Massler et al.
MOLECULAR CANCER RESEARCH (2009)
Transcriptional repression of p53 by parkin and impairment by mutations associated with autosomal recessive juvenile Parkinson's disease
Cristine Alves da Costa et al.
NATURE CELL BIOLOGY (2009)
Epidermal growth factor receptor inhibitors in neuro-oncology: Hopes and disappointments
Alba A. Brandes et al.
CLINICAL CANCER RESEARCH (2008)
Linking Heterochromatin Protein 1 (HP1) to cancer progression
George K. Dialynas et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2008)
Transcription regulation by mutant p53
L. Weisz et al.
ONCOGENE (2007)
TP53: a key gene in human cancer
DP Guimaraes et al.
BIOCHIMIE (2002)
Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain
AJ Bannister et al.
NATURE (2001)
Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins
M Lachner et al.
NATURE (2001)
Untangling the ErbB signalling network
Y Yarden et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)
Share Paper
